Compare PRGO & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRGO | PAHC |
|---|---|---|
| Founded | 1887 | 1946 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 1991 | 2014 |
| Metric | PRGO | PAHC |
|---|---|---|
| Price | $13.25 | $40.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $22.50 | ★ $31.25 |
| AVG Volume (30 Days) | ★ 4.1M | 316.9K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 8.63% | 1.23% |
| EPS Growth | N/A | ★ 288.74 |
| EPS | N/A | ★ 1.67 |
| Revenue | ★ $4,281,800,000.00 | $1,399,676,000.00 |
| Revenue This Year | N/A | $15.34 |
| Revenue Next Year | N/A | $3.28 |
| P/E Ratio | ★ N/A | $23.44 |
| Revenue Growth | N/A | ★ 33.72 |
| 52 Week Low | $12.17 | $16.16 |
| 52 Week High | $30.93 | $46.42 |
| Indicator | PRGO | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 31.07 | 44.27 |
| Support Level | $13.34 | $38.27 |
| Resistance Level | $14.12 | $41.94 |
| Average True Range (ATR) | 0.47 | 1.85 |
| MACD | 0.32 | -0.50 |
| Stochastic Oscillator | 55.64 | 29.42 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.